FDA warns Pfizer about Celebrex, Bextra ads

01/13/2005 | Reuters · MarketWatch

The FDA has warned Pfizer that its ads for arthritis drugs Celebrex and Bextra are misleading and fail to include information on adverse side effects of the painkillers. The agency's letter to Pfizer said the advertising campaign made "unsubstantiated effectiveness claims." A Pfizer spokeswoman said the Celebrex ads were no longer running, but she had no comment on the Bextra ads. She added that the company would work with the FDA to explore "appropriate" next steps.

View Full Article in:

Reuters · MarketWatch

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Director - Web Marketing
The Culinary Institute of America
Hyde Park, NY
Sales Manager
Multiple Locations, SL_Multiple Locations
Austin, TX
Product Marketing Manager-B2C
Austin, TX
Partner Manager
Austin, TX